Metformin drives a phenotypic shift away from fat accumulation via AMPK-NAMPT-SIRT1-mediated alterations in clock components, providing support for chronotherapeutic approaches to the treatment of obesity [172]. Here, CLOCK is linked to obesity due to melanocortin 4 receptor deficiency.